Joseph Huegler
About Joseph Huegler
Joseph Huegler is the Planning & Execution Lead for Global Biometric Sciences at Bristol-Myers Squibb, with extensive experience in program management and IT consulting.
Title and Current Role
Joseph Huegler is the Planning & Execution Lead in Global Biometric Sciences at Bristol-Myers Squibb. In this role, he is responsible for overseeing various aspects of planning and execution within the Global Biometric Sciences division, ensuring that projects are efficiently managed and objectives are met.
Previous Experience at Bristol-Myers Squibb
Joseph Huegler has extensive experience with Bristol-Myers Squibb, having held several significant positions within the company. He served as a Program Manager for R&D IT from 2010 to 2017, Vendor Management in IM Shared Services from 2008 to 2010, and in the Program Management Office for Global Development Informatics from 2000 to 2008. He also briefly worked as a Program Manager, R&D IT-Consultant in 2018.
Experience at Otsuka Pharmaceutical Companies
In addition to his roles at Bristol-Myers Squibb, Joseph Huegler worked at Otsuka Pharmaceutical Companies (U.S.) as a Program Manager, Enterprise IT-Consultant, from 2017 to 2018. During his tenure, he focused on managing enterprise IT projects and consulting on technology solutions.
Education and Expertise
Joseph Huegler holds a Master of Business Administration (MBA) from Drexel University - LeBow College of Business and a Bachelor of Science (BS) from Albright College. His educational background provides a strong foundation in business administration and science, which supports his roles in program management and IT consultancy.
Notable Projects and Implementations
Joseph Huegler has directed several complex, multi-vendor IT programs valued between $5M-10M+, leading to successful, on-time, and on-budget delivery. He captured over $2M+ in annual savings through improved operational efficiency. Additionally, he improved clinical trial operational data quality with a new technical platform, implemented standardized clinical trial payment processing, and established a new contract and vendor management capability for $100M annual global outsourcing. He also implemented a new Program Management Office to oversee a $100M+ investment, significantly upgrading BMS R&D clinical development systems.